|
#1
16.09.2019, 06:03
|
|||
|
|||
|
Äåìåíöèè ñ òåëüöàìè Ëåâè áîëüøå íåò
Îò êîëëåã íåâðîëîãîâ óçíàë, ÷òî ïîÿâèëèñü ñîîáùåíèÿ î òîì, ÷òî íîçîëîãèÿ -äåìåíöèÿ ñ òåëüöàìè Ëåâè áîëüøå íå ñóùåñòâóåò. Ýòî ïàòîëîãèþ èíòåðåïðåòèðóþò ïî äðóãîìó è ïîäõîäû ê ëå÷åíèþ ñîîòâåòñòâåííî áóäóò ìåíÿòüñÿ. Õîòåëîñü áû óòî÷íèòü , òàê ëè ýòî
|
|
#6
19.09.2019, 10:16
|
||||
|
||||
|
Ó íàñ íèêàêèõ èçìåíåíèé â íîçîëîãèè íåò. àêòóàëèçèðîâàíèÿ íà ñàéòå ñîîáøåñòâà íåâðîëîãîâ Ãåðìàíèè ÿ íå íàøëà. Òàê ÷òî êàê íàçûâàëè, òàê è íàçûâàþò äî ñèõ ïîð.
|
|
#7
30.09.2019, 16:59
|
||||
|
||||
|
Òåðìèíîëîãèÿ íà ñåãîäíÿøíèé äåíü (ÿíâàðü 2019 ãîäà):
"Äåìåíöèÿ ñ òåëüöàìè Ëåâè" íàèáîëåå ïðåäïî÷ò. òåðìèí-ñëîâîñî÷åòàíèå âìåñòî "äèôôóçíàÿ á-íü ñ òåëüöàìè Ëåâè" è ïðî÷èõ ïåðå÷èñëåííûõ íèæå Dementia with Lewy bodies (DLB) is now the preferred term [8, 10, 11] for a variety of previously used clinical diagnoses including diffuse LB disease (DLBD) [15–17], LB dementia [18], dementia associated with cortical Lewy bodies (DCLB) [19], the LB variant of Alzheimer’s disease (LBVAD) [20, 21], and senile dementia of LB type (SDLT) [22]. --- Dementia with Lewy bodies: an update and outlook [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ëå÷åíèå íà ñåã. äåíü (àïðåëü 2019) Pharmacological Management of Dementia with Lewy Bodies [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#8
30.09.2019, 17:03
|
||||
|
||||
|
Ñàìûé ïîñëåäíèé ìåæäóíàðîäíûé àïäåéò ïî áîëåçíè áûë â 2017 ãîäó:
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
Ëèíåéíûé âèä
